Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
(5S)-4-(2,2-Dimethyl-prop-yl)-5-isopropyl-1,3,4-oxadiazinan-2-oneKate L Edler, Sharon E E Kirk, Ryan A Davis, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 1, 1996
Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteineR Kinscherf, V Hack, T Fischbach, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1993
Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessmentC Portier, A Tritscher, M Kohn, et al.
Onkologie|December 1, 1990
Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer SocietyM E Heim, R Siegmund, H J Illiger, et al.
Journal of Toxicology and Environmental Health|May 1, 1997
Elimination of beta-hexachlorocyclohexane in occupationally exposed personsD Jung, H Becher, L Edler, et al.
Onkologie|February 1, 1990
[Diabetes mellitus and breast cancer. A retrospective follow-up study]P Unterburger, A Sinop, W Noder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer SocietyK Mross, C Bohn, L Edler, et al.
Cancer Research|February 24, 2001
p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer developmentI Zehbe, G Voglino, E Wilander, et al.
Onkologie|December 1, 1986
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancerD Fritze, W Queisser, H Schmid, et al.
Onkologie|June 1, 1990
Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer SocietyW Queisser, P Preusser, K B Mross, et al.
Pageof 16